Pharmaceutical Co., Ltd. MEDICINE CNS/ENDOCRINOLOGY DEVELOPMENT LICENSING COMPANY PROFILE
|
|
- Spencer Lucas
- 5 years ago
- Views:
Transcription
1 WHANIN Pharmaceutical Co., Ltd. MEDICINE CNS/ENDOCRINOLOGY DEVELOPMENT LICENSING COMPANY PROFILE
2 Board of Directors Chairman Vice Chairman President & CEO Vice President, Marketing Director (non-standing) Auditor Mr. Kwang Sik Lee Mr. Keung Lim Kim Mr. Kye Kwan Lee Mr. Kye Ihl Whang Mr. Chong Seok Lee Mr. Hyae Moon Bae Mr. Ki Ock Chang Mr. Chong Dae Kim
3 Management Team Chairman Vice Chairman President & CEO Vice President Sr. Executive Director Executive Director Executive Director Director Director Director Director Director Director KS Lee KL Kim KK Lee KI Hwang SJ Choi BR Park DW Kim KS Hah MS Lee JS Kim SK Park SI Chang SW Lee Founder Sales & Marketing Corporate Sales Marketing Manufacturing Strategy Planning & Adm. BD & Licensing New Product Plan & Regulatory Quality Control Sales Finance
4 Distribution of Shares Name Relation with company Number of Shares % As of Jan. 31, 2003 Kwang Sik Lee Chairman/ Founder 422, Ho Il Park Corp. Consultant 102, Keung Lim Kim Vice President 42, SSB-BAUPOST GL 100, JPMCB-L-R GLB PTNRSLP - 95, ATLANTIS KOREAN SMALLER Other Foreign Investor Shinhan Bank WhanIn Pharm Others Treasury Stock Own Stock Fund 65,880 19, , , ,
5 History Summary Jun, 1978 Dec.1982 Oct Oct Jul Aug.1998 Mar Feb Jan Established as a private owned company Transformed into a limited company Completed KGMP factory at Ansung-city Established Central Research Laboratory Enlisted Korean Stock Exchange Market (Public Company) Korean Good Supply Practice approved Increased the Capital to 9,700 million Won, equivalent USD Million 8.1 Strategic Alliance Signing with Scigenic Corp. for New Drug Development: Alzheimer Drug and 4 New pipelines Mr. Kye-Kwan Lee become new CEO & President
6 Employees Administration 39 (12.4%) R&D 18 (5.7%) Sales & Marketing 172 (54.6%) Production 86 (27.3%) Sales & Marketing 172 ( 54.6%) Administration 39 ( 12.4%) Plant 86 ( 27.3%) R&D 18 ( 5.7%) Total 315(100.0%) As of Jan. 1, 2004
7 Sales/Profit Status: Sales Net Profit Unit : Million Won( ) 55,000 50,000 45,000 40,000 38,680 44,793 48,731 54,000 35,000 31,807 30,000 25,000 23,852 24,436 27,038 20,000 15,000 10,000 5, ,949 9,461 7,095 4,615 9,500 1,994 1,561 2, Year Ended December 31 Ref. Exchange rate : 1,200/USD
8 Operation Status million Won Net income Operating income Ordinary income Estimate Sales 38,679 44,793 48,731 54,000 Operating Income 9,216 11,543 12,558 13,000 Ordinary Income 9,473 13,801 13,665 13,500 Net Income 7,094 8,948 9,461 8,500 Year Ended December 31 Unit: Million Won, Foreign. Exchange rate : W1,200/USD
9 Leading Products Value million Won 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1, Alend Tab. Grandaxin Tab. Ubacillin inj. Alpram Tab. Acamprol Tab Alend Tab Osteoporosis treatment 4,317 6,890 7,130 Grandaxin Tab Tranquilizer 3,130 4,318 4,318 Ubacillin Inj Antibiotic 3,508 2,046 1,496 Alpram Tab Tranquilizer 2,299 2,333 2,410 Acamprol Tab Antialcoholism 925 1,857 2,120
10 Revenue 2002 by Therapeutic class 16% 5% 7% 6% Cardiovascular drugs Others Psychotherapeutics 11% Antimicrobials GI tract drugs 9% 9% 40% NSAIDs Osteoporosis agents Topical As of Dec. 31, 2002
11 Foreign Tie-ups License Agreement Suntory (Japan) Yamanouchi Pharm. (Japan) Lundbeck A/S (Denmark) RPR (Pharmuka S.F. : France) Lisapharma (Italy) Hovion (Portugal) Egis (Hungary) Gador (Argentina) Distribution Agreement Doetsch Grether AG (Swiss) Celltech (USA) HANP Inj. (Carperitide ) Neponid Tab. (Nemonapride ) Clopixol Tab. (Zuclopenthixol ) Cipram Tab. (Citalopram ) Kinupril Tab. (Quinupramine ) Pirxane Cap. (Buflomedil pyridoxal Phosphate ) Dexaderm Cream (Dexamethasone propionate ) Grandaxin Tab. (Tofisopam ) Alend (Alendronate ) Sulgan99 Oint./Supp. Zaroxolyn (Metolazone ) Acute Heart Failure Antipsychotic Antipsychotic Antidepressant Antidepressant Cerebral & Peripheral Vasodilator Non habit Forming Tranquilizer Osteoporosis Treatment Antihemorrhoid Diuretic
12 Branch Regional Offices: Total 16
13 Factory Dosage Forms : Tablets Capsules Injections (Ampoule, Vial, Penicillin) Topicals (Cream, Ointment, Solution) Oral Liquids Land Space : 10,000 m 2 Building Space : 9,000 m 2 Location : Ansung city, Kyungki-do
14 Balance Sheet (Unit : Million Won) Ref. Exchange rate : 1,200/US$ Dec. 31,2002 Dec.31,2001 Dec. 31,2000 Assets 64,701 58,453 59,030 Current Assets 48,742 41,634 41,343 Non-Current Assets 15,960 16,819 17,687 Liabilities 7,985 10,462 12,228 Current Liabilities 6,180 8,894 8,819 Fixed Liabilities 1,836 1,568 3,409 Shareholders equity 56,685 47,991 46,802 Debt ratio(%)
15 Income Statement (Unit : Million Won) Ref. Exchange rate : 1,200/USD Year Ended December Sales 48,731 44,792 38,680 Cost of Sales 17,748 16,314 14,817 Gross Profit 30,983 28,478 23,863 Operating Income 12,558 11,542 9,217 Ordinary Income 13,665 13,080 9,474 Income Taxes 4,205 4,132 2,379 Net Income 9,461 8,948 7,095
Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
More informationIR Presentation. March 2014
IR Presentation March 2014 1 Table of Contents 1. 4Q13 Earnings Summary - Financial Highlights 2. Service & Business Strategy 3. Mobile 4. PC - Developing Quality Contents - Growth Strategy - Expanding
More informationNOTICE OF THE 5TH ANNUAL GENERAL MEETING OF SHAREHOLDERS
Note: This document is a translation of a part of the Japanese original. The translation is prepared and provided for the purpose of the readers convenience only. All readers are strongly recommended to
More informationConfirms 2013 Financial Guidance
Confirms 2013 Financial Guidance PROVIDENCE, R.I.--(BUSINESS WIRE)--Jul. 17, 2013-- Textron Inc. (NYSE: TXT) today reported second quarter 2013 income from continuing operations of $0.40 per share, compared
More informationNOTICE OF THE 42ND ORDINARY GENERAL MEETING OF SHAREHOLDERS
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the
More informationLupin Limited Annual Results FY12. Investor Presentation May being
Lupin Limited Annual Results FY12 Investor Presentation May 2012 Vision: To be an innovation led transnational company Journey over the last decade 5th largest generics player in US Gross Revenues INR
More informationPhoenix Semiconductor Philippines Corp (PSPC) to be listed on December 1, Semiconductor historical billings report in 000 US$
Report date: November 10, 2014 Phoenix Semiconductor Philippines Corp (PSPC) to be listed on December 1, 2014 Recommendation: Cautious buy with target price of Php 3.81/share At the final offer price of
More informationTextron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5%
Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5% 07/16/2014 PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported
More informationBayport Securitisation (RF) Ltd Investor Report February 2013
Bayport Securitisation (RF) Ltd Investor Report February 2013 Financial statistics for the period ended February 2013 Feb 13 Jan 13 Dec 12 Nov 12 Oct 12 Sep 12 Aug 12 Jul 12 Jun 12 May 12 Apr 12 Mar 12
More informationBayport Securitisation (RF) Ltd Investor Report May 2013
Bayport Securitisation (RF) Ltd Investor Report May 2013 Financial statistics for the period ended May 2013 May 13 Apr 13 Mar 13 Feb 13 Jan 13 Dec 12 Nov 12 Oct 12 Sep 12 Aug 12 Jul 12 Jun 12 Performance
More informationBAYPORT SECURITISATION (RF) LTD INVESTOR REPORT DECEMBER 2014
BAYPORT SECURITISATION (RF) LTD INVESTOR REPORT DECEMBER 2014 Financial statistics for the period ended December 2014 Dec 14 Nov 14 Oct 14 Sept 14 Aug 14 Jul 14 Jun 14 May 14 Apr 14 Mar 14 Feb 14 Jan 14
More informationTextron Reports Third Quarter 2014 Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1%
Textron Reports Third Quarter Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1% 10/17/ PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported third
More informationTable of Contents. 1. 4Q13 Earnings Summary - Financial Highlights. 2. Service & Business Strategy. 3. Mobile 4. PC. 5. Appendix
1 Table of Contents 1. 4Q13 Earnings Summary - Financial Highlights 2. Service & Business Strategy 3. Mobile 4. PC - Developing Quality Contents - Growth Strategy - Expanding Development - CGP & Investment
More informationTextron Reports First Quarter 2016 Income from Continuing Operations of $0.55 per Share, up 19.6%; Reaffirms 2016 Financial Outlook
Textron Reports First Quarter 2016 Income Continuing Operations of $0.55 per Share, up 19.6%; Reaffirms 2016 Financial Outlook April 20, 2016 06:30 AM Eastern Daylight Time PROVIDENCE, R.I.--(BUSINESS
More informationSupplementary data for MLP SE (in line with the German
Supplementary data for MLP SE (in line with the German Commercial Code ( GB)) In contrast with the consolidated financial statements, the financial statements of MLP SE are not prepared to International
More informationTo our shareholders Onna, Atsugi-shi, Kanagawa, Japan
To our shareholders June 6, 2016 Hirokazu Hashimoto, Representative Director ANRITSU CORPORATION 5-1-1 Onna, Atsugi-shi, Kanagawa, Japan Notice of the 90 th Ordinary General Meeting of Shareholders This
More informationInvestor Presentation & Financial Highlights. May 2018
Investor Presentation & Financial Highlights May 2018 Forward Looking Statements Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual
More informationReference materials for proposal at General Meeting of Shareholders
Reference materials for proposal at General Meeting of Shareholders Proposal: Election of Eight Directors The term of office of all the nine Directors shall expire as of the end of this Ordinary General
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationNorth China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationThe term of office of all the eleven Directors shall expire as of the end of the
Reference Material for the General Meeting of Shareholders Proposal: Election of Twelve Directors The term of office of all the eleven Directors shall expire as of the end of the Ordinary General Meeting
More informationSecurities Code: 6412 June 7, To Those Shareholders with Voting Rights
This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original
More informationThe 44 th AGM Material
The 44 th AGM Material February 2013 Samsung Electronics Table of Contents 1. Proxy Material 1.1 Agenda of the Meeting 1.2 Attachments 1 Notice of the Convening of the AGM 2 Financial Statements (B/S,
More information2Q 2017 Results. 11 Aug 2017 MERMAID MARITIME PUBLIC COMPANY LIMITED
MERMAID MARITIME PUBLIC COMPANY LIMITED 2Q 2017 Results 11 Aug 2017 1 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated
More informationNotice of the 57th Annual General Meeting of Shareholders
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the
More information2018 1Q IR PRESENTATION
2018 1Q IR PRESENTATION Investor Relation March 2018 Disclaimer These materials have been prepared by GRAVITY Co., Ltd. ("Gravity" or the "Company"). The statements contained in this presentation have
More informationA Presentation for Prospective Investors & Partners. Feb 2004
A Presentation for Prospective Investors & Partners Feb 2004 Overview Financial Highlights Services & Products Company Profile Shareholding Structure Neowiz at a Glance Management 2004 Outlook Company
More information1Q 2016 Results. Mermaid Maritime Plc. May 23, 2016
Mermaid Maritime Plc 1Q 2016 Results May 23, 2016 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed to
More informationHBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio
HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company
More informationFor personal use only
ASX ANNOUNCEMENT AGM PRESENTATION SYDNEY, Monday 21 November 2016: Cellmid Limited (ASX:CDY) provides the following presentation for the Annual General Meeting of the shareholders. End Contact: Maria Halasz,
More informationCONVOCATION NOTICE OF THE 22ND ANNUAL SHAREHOLDERS MEETING
CONVOCATION NOTICE OF THE 22ND ANNUAL SHAREHOLDERS MEETING Date and Time: Friday, June 23, 2017 10:00 a.m. Venue: Keidanren Kaikan Conference Rooms #401 402 1 3 2 Otemachi, Chiyoda ku, Tokyo Shareholders
More informationDo Mid-Cap Private Equity Funds Have an Advantage in Today s Markets?
Do Mid-Cap Private Equity Funds Have an Advantage in Today s Markets? Richard Cashin, Managing Partner, One Equity Partners Ellis Jones, CEO, Wasserstein & Co. John Mapes, Managing Partner, Aurora Capital
More information5-1-1 Onna, Atsugi-shi, Kanagawa, Japan
To our shareholders June 6, 2017 Hirokazu Hashimoto, Representative Director ANRITSU CORPORATION 5-1-1 Onna, Atsugi-shi, Kanagawa, Japan Notice of the 91 st Ordinary General Meeting of Shareholders This
More informationTextron Reports Third Quarter 2018 Results; Narrows Full-Year EPS and Cash Guidance
Corporate Communications Department NEWS Release Textron Reports Third Quarter 2018 Results; Narrows Full-Year EPS and Cash Guidance $468 million returned to shareholders through share repurchases Completed
More informationAugust 7, 2014 Heiwa Corporation
August 7, 2014 Heiwa Corporation Contents Overview 3 1 st Quarter Results of FY Ending March 2015 4 Full-year Plan for FY2015 12 < Supplementary Information > Market Environment (Pachinko and Pachislot
More informationThe partner of choice for self-care products
The partner of choice for self-care products Venture Life Group plc Full Year Results Presentation 2017 22 March 2018 2017 highlights Revenues up 12% to 16.1m (2016: 14.3m) Gross profit increased 18% to
More informationAnnouncement Regarding Candidates for Director and Member Composition of the Three Committees of ORIX Corporation
Announcement Regarding Candidates for Director and Member Composition of the Three Committees of ORIX Corporation TOKYO, Japan May 9, 2018 ORIX Corporation (TSE: 8591; NYSE: IX) today made public an announcement
More informationCannabis Practice Group
Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments
More informationSejaya Micro Credit. Company Profile. October 2016
Sejaya Micro Credit Company Profile October 2016 Company Profile We founded Sejaya to provide the genuine microfinance service in Sri Lanka. Basic Information Corporate Status: Public Limited Liability
More informationNOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA
Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on
More information2Q 2016 Results. Mermaid Maritime Plc. August 2016
Mermaid Maritime Plc 2Q 2016 Results August 2016 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed to
More informationContent Ⅰ. OVERVIEW. Ⅱ. SNG & Mobile Game. Ⅲ. Online Game. Ⅳ. Appendix. Company Overview Business Overview Strategic Goals
INVESTOR RELATIONS 2012 Content Ⅰ. OVERVIEW Company Overview Business Overview Strategic Goals Ⅱ. SNG & Mobile Game R&D Superiority Global Expansion Strategy - Domestic Strategy - Japan Ⅲ. Online Game
More informationAugust 5, 2016 Heiwa Corporation. Securities Code : 6412
August 5, 2016 Heiwa Corporation Securities Code : 6412 Contents Overview 3 Results for the 1st Quarter of FY ending March 31, 2017 4 Full-year Plan for FY ending March 31, 2017 13 Supplementary Information
More informationIn the quarter, Textron returned $344 million to shareholders through share repurchases, compared to $186 million in the first quarter of 2017.
Corporate Communications Department NEWS Release Textron Reports First Quarter 2018 Income from Continuing Operations of $0.72 per Share; Signs Agreement to Sell Tools & Test Business for $810 Million
More informationFinancial Results Briefing Session
Financial Results Briefing Session Six-Month Period Ended September 30, 2017 November 8, 2017 SQUARE ENIX HOLDINGS CO., LTD. Statements made in this document with respect to SQUARE ENIX HOLDINGS CO., LTD.
More informationThe 43 rd AGM Material
The 43 rd AGM Material February 2012 Samsung Electronics Table of Contents 1. Notice of the Convening of the AGM 2. Details of Agenda [Attachment ] - Pre/Post-Split Financial Position - Financial Statements
More informationAnnouncement of the US Business Restructuring
August 15, 2018 Shin Nippon Biomedical Laboratories, Ltd. (The First Section of the Tokyo Stock Code Number: 2395) Representative: Chairman and President Ryoichi Nagata C o n t a c t : Senior Executive
More informationNAM LONG INVESTMENT CORPORATION MANAGEMENT PRESENTATION
NAM LONG INVESTMENT CORPORATION MANAGEMENT PRESENTATION Gateway to Vietnam 2010 Intercontinental Hotel Saigon 11 November 2010 DEVELOPMENT MILESTONES 2 18 years of Real Estate development experience 1996
More informationCONVOCATION NOTICE OF THE 57th ANNUAL MEETING OF SHAREHOLDERS
This document has been translated from the Japanese original for the convenience of non-japanese shareholders. In the event of any discrepancy between this document and the Japanese original, the original
More informationBumrungrad Hospital Public Company Limited
Roadshow Bumrungrad Hospital Public Company Limited Investor Presentation April 2008 1 Company Highlights Bangkok Facility Construction of 7 additional floors (of which 4 are outpatient clinics) of the
More informationNotice of Convocation of the 102nd Ordinary General Meeting of Shareholders
Disclaimer: This is an English abridged translation of the original Notice of Convocation of the 102nd Ordinary General Meeting of Shareholders of Matsui Securities Co., Ltd. written in Japanese (the Original
More informationNotice of the 19th Annual General Meeting of Shareholders
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the
More informationEXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.
An innovative new system for Supply Chain Financing that is so disruptive that it will revolutionize the way in which practices in B2B trading relationships occur. has invented a system that revolutionizes
More informationQ Interim Report
Interim Report Aug 15, Today s presenter: Lars Wingefors Co-Founder & Group CEO 1 highlights Net sales SEK 837m EBITDA SEK 207m EBIT SEK 53m YoY growth 878% YoY growth 421% YoY growth 73% 10 releases in
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationCapcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) 3rd Quarter Report Fiscal year ending March 31, 2018
Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) 3rd Quarter Report Fiscal year ending March 31, 2018 0 Forward-looking Statements Strategies, plans, outlooks and other statements that are
More informationReference Materials Nine Month Period Ended December 31, 2018
Reference Materials Nine Month Period Ended December 31, 2018 February 5, 2019 SQUARE ENIX HOLDINGS CO., LTD. Statements made in this document with respect to SQUARE ENIX HOLDINGS CO., LTD. and its consolidated
More informationFebruary 9, 2017 Heiwa Corporation. Securities Code : 6412
February 9, 2017 Heiwa Corporation Securities Code : 6412 Contents Overview 3 Results for the 3rd Quarter of FY ending March 31, 2017 4 Full-year Plan for FY ending March 31, 2017 13 Supplementary Information
More information2003 ANNUAL REPORT TOOLS FOR NANOTECH
2003 ANNUAL REPORT TOOLS FOR NANOTECH FEI REVENUES In Millions of Dollars 400 350 300 250 200 150 100 50 94 95 96 97 98 99 00 01 02 03 OPERATING INCOME In Millions of Dollars 60 50 40 30 20 10 0 94 95
More informationALANCO TECHNOLOGIES INC
SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution
More informationSEKISUI CHEMICAL CO., LTD.
[Translation: Please note that the following purports to be an accurate translation of excerpt contents of the original Japanese document, prepared for foreign shareholders solely as a reference material.
More informationAnnouncement Regarding Candidates for Director and Member Composition of the Three Committees of ORIX Corporation
Announcement Regarding Candidates for Director and Member Composition of the Three Committees of ORIX Corporation TOKYO, Japan May 15, 2017 ORIX Corporation (TSE: 8591; NYSE: IX) today made public an announcement
More informationNotice of the 11th Annual General Meeting of Shareholders
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original
More informationHISTORY, REORGANISATION AND CORPORATE STRUCTURE
HISTORY AND BUSINESS DEVELOPMENT Our Company was established as a joint stock limited company under the PRC Company Law on 11 May 2015, converting from our predecessor Yichang Changjiang Pharmaceutical
More informationInterim Report January March
Report on 1996 Operations 97 Interim Report January March Continued stable earnings during first quarter of 1997. Higher operating income despite modest decline in sales. Decline in cigarette sales in
More informationNotice of the 56th Annual General Meeting of Shareholders
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the
More information2013 Processing Schedule
Federal Reserve Bank of Dallas - Statistics Department Federal Reserve Bank of Dallas Statistics Department Regulatory Reporting 2013 Processing Schedule (214) 922-5401 dallas-statistics@dal.frb.org Fax:
More informationKOHLBERG CAPITAL CORPORATION. May 2007
KOHLBERG CAPITAL CORPORATION May 2007 Safe Harbor Statement Private Securities Litigation Reform Act of 1995 Forward Looking Information This presentation may include forward-looking statements. These
More informationNotice of the 62 nd Ordinary General Meeting of Shareholders
Notice of the 62 nd Ordinary General Meeting of Shareholders June 24, 2016 Kyoto, Japan 6 Takeda Tobadono-cho, Fushimi-ku, Kyoto, Japan Please note that this is an English translation of the Japanese original
More informationFinancing SMEs and Entrepreneurs 2012
Financing SMEs and Entrepreneurs 2012 AN OECD SCOREBOARD OECD Table of Contents Acronyms and abbreviations 13 Chapter 1. Financing SMEs and Entrepreneurs: Understanding and Developing an OECD Scoreboard
More informationannual MEETING 2013 _ 30 october 2013 //
annual MEETING 2013 30 october 2013 // AGENDA // Chairman s report // A few words from the directors // Chief executive s report // CFO report // Ordinary business // Election of the directors // Appointment
More informationINVESTOR PRESENTATION!
INVESTOR PRESENTATION ENHANCING HEALTH THROUGH CANNABIS SCIENCE WWW.EMERALDHEALTH.CA TSX.V:EMH TSX.V:EMH Disclaimer THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD-LOOKING STATEMENTS REGARDING
More informationFOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
More informationCompany Profile Series
Company Profile Series Table of Content The Basics... 3 Key Information...4 Key Numbers...4 Key Executives...5 Company Structure... 6 Company History... 7 Interests in Associates... 8 Industry Analysis...
More informationLUPIN LIMITED Q3FY17 Investor Presentation February 09, 2017
LUPIN LIMITED Investor Presentation February 09, 2017 Safe Harbor Statement Materials and information provided during this presentation may contain forward-looking statements. These statements are based
More informationSecond Quarter CY 2012 Results. August 2, 2012
Second Quarter CY 2012 Results August 2, 2012 1 Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts
More informationMOVING WATER. MOVING FUEL. MOVING FORWARD.
MOVING WATER. MOVING FUEL. MOVING FORWARD. ANNUALREPORT2013 SEPTEMBER 2013 COMPLETED RELOCATION TO OUR NEW WORLD HEADQUARTERS Franklin Electric Co., Inc. 9255 Coverdale Road Fort Wayne, Indiana 46809 telephone:
More informationSecond Quarter 2013 Results August 1, 2013
Second Quarter 203 Results August, 203 2 Safe Harbor Disclosure Please review our SEC filings on Form 0-K and Form 0-Q The statements contained in this presentation that are not historical facts are forward-looking
More informationCapcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018
Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018 0 0 Forward-looking Statements Strategies, plans, outlooks and other statements
More informationKKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018
KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018 KKR Today Private Markets Public Markets Capital Markets Principal Activities $104bn AUM $91bn AUM Global Franchise $19bn
More informationThe Migdal Group Organizational Structure
Company Profile The Migdal Group Organizational Structure Public 69.15% 9.8% Migdal Insurance 21.05% 100% Migdal Capital Markets Alternative Investments Mutual Funds Underwriting and Business Initiatives
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationGerresheimer CAPITAL MARKETS DAY 2010
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO Gerresheimer who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. TEXTRON INC. (Exact name of Registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationState Capitalism and the Chinese Firm: Legal and Policy Issues
State Capitalism and the Chinese Firm: Legal and Policy Issues Curtis J. Milhaupt Columbia Law School Lin & Milhaupt, Stanford Law Review (2013) Milhaupt & Zheng, Georgetown Law Journal (2015) Milhaupt,
More informationReport on Operations 1999
Report on Operations 1999 Sales increased 15 percent to MSEK 9,420 Operating income, before items affecting comparability, increased 13 percent to MSEK 1,689 (1,489) Operating income, including capital
More informationCOURSE SCHEDULE
2018-2019 COURSE SCHEDULE Fall 1 Seven-Week: Aug. 27 Oct. 12, 2018 Business Formation & Structure -11:40am Legal & Regulatory Process ` Patent Business Formation & Structure -11:40am Research in, Business
More informationTainan Enterprises Co., LTD. Date: Feb. 20, 2009
Tainan Enterprises Co., LTD Date: Feb. 20, 2009 1. Company Profile Date of Establishment: 26 August, 1961 Chairman: Mr. Yang Ching-Hon Headquarters and Plant Location: Tainan Headquarters: No.320, Sec.
More informationStandard Chartered PLC Board Member Visits Ghana
Standard Chartered PLC Board Member Visits Ghana Accra 4 June 2006 -- Mr. Richard Meddings, member of the Board of Standard Chartered PLC and Group Executive Director of Standard Chartered Bank with responsibility
More information3Q 2016 Results. Mermaid Maritime Plc. 14 November 2016
Mermaid Maritime Plc 3Q 2016 Results 14 November 2016 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed
More informationAnnual Shareholders' Meeting. Stuttgart May 14th 2009
Annual Shareholders' Meeting Stuttgart May 14th 2009 HUGO BOSS in 2008 in EUR mill. Net Sales 1.686 + 6% (fx-adj.) + 3% Gross Profit 1.011 + 7% EBIT before extraordinary items 226 + 9% Cash Flow from operating
More informationKKR Credit Advisors (Ireland) Unlimited Company PILLAR 3 DISCLOSURES
KKR Credit Advisors (Ireland) Unlimited Company KKR Credit Advisors (Ireland) Unlimited Company PILLAR 3 DISCLOSURES JUNE 2017 1 1. Background The European Union Capital Requirements Directive ( CRD or
More informationPower4Georgians: Follow the Money
Power4Georgians: Follow the Money 4 3 Cooperative Energy, Inc. Dwight Brown 5 2 8 Alumni Properties Buster & Brown Properties, LLC 6 9 0 Washington Timberland, LLC 4 Washington County Development Authority
More informationAgenda and Explanatory Notes of the Annual General Meeting of Shareholders of AMG Advanced Metallurgical Group N.V.
Agenda and Explanatory Notes of the Annual General Meeting of Shareholders of AMG Advanced Metallurgical Group N.V. Wednesday, May 2, 2018 at 13:00 CEST World Trade Centre (WTC), Strawinskylaan 15, 1077
More informationJanuary September Summary
January September 2012 - Summary Consolidated revenue for the period is 60 239 KSEK, up 93% compared to 31 207 KSEK for the same period of 2011. This is in line with the previously communicated forecast
More informationAnnouncement Regarding Candidates for Director and Member Composition of the Three Committees of ORIX Corporation
May 8, 2014 FOR IMMEDIATE RELEASE Contact Information: ORIX Corporation Corporate Planning Department Tel : +81-3-3435-3121 Fax: +81-3-3435-3154 URL: http://www.orix.co.jp/grp/en/ Announcement Regarding
More informationRe: Management Changes for the Mizuho Financial Group
To whom it may concern April 22, 2014 Company Name: Mizuho Financial Group, Inc. Representative: Yasuhiro Sato, President & CEO Address: 1-5-5 Otemachi, Chiyoda-ku, Tokyo Security Code: 8411 (Tokyo Stock
More informationNotice of the 54th Annual General Meeting of Shareholders
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the
More informationInvestor Presentation & Financial Highlights. November 2018
Investor Presentation & Financial Highlights November 2018 Forward Looking Statements Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties.
More informationMesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile
Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More information